Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Operating Leases (2019 - 2025)

Historic Operating Leases for Dexcom (DXCM) over the last 9 years, with Q4 2025 value amounting to $95.0 million.

  • Dexcom's Operating Leases rose 4615.38% to $95.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $95.0 million, marking a year-over-year increase of 4615.38%. This contributed to the annual value of $95.0 million for FY2025, which is 4615.38% up from last year.
  • Per Dexcom's latest filing, its Operating Leases stood at $95.0 million for Q4 2025, which was up 4615.38% from $50.6 million recorded in Q3 2025.
  • Over the past 5 years, Dexcom's Operating Leases peaked at $111.3 million during Q1 2021, and registered a low of $50.6 million during Q3 2025.
  • In the last 5 years, Dexcom's Operating Leases had a median value of $85.1 million in 2023 and averaged $83.3 million.
  • Data for Dexcom's Operating Leases shows a peak YoY increase of 4615.38% (in 2025) and a maximum YoY decrease of 2883.26% (in 2025) over the last 5 years.
  • Over the past 5 years, Dexcom's Operating Leases (Quarter) stood at $98.6 million in 2021, then dropped by 4.06% to $94.6 million in 2022, then fell by 15.33% to $80.1 million in 2023, then decreased by 18.85% to $65.0 million in 2024, then surged by 46.15% to $95.0 million in 2025.
  • Its last three reported values are $95.0 million in Q4 2025, $50.6 million for Q3 2025, and $54.7 million during Q2 2025.